Mandatory reporting and improvements in diagnosing Clostridium difficile infection: An incompatible dichotomy?

Journal of Infection

Volumn 62, Issue 5, 2011, Pages 363-370

  Goldenberg, Simon D ^a,b   Price, Nicholas M ^a   Tucker, David ^a   Wade, Paul ^a   French, Gary L ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Clostridium difficile; Molecular diagnostics; Sensitivity and specificity

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN B; GLUTAMATE DEHYDROGENASE;

ADULT; AGED; ALGORITHM; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FECES ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MANDATORY REPORTING; OUTCOME ASSESSMENT; PATIENT SAFETY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; TOXIN ANALYSIS;

AGED; AGED, 80 AND OVER; ALGORITHMS; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; MANDATORY REPORTING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 79956129482     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.03.007     Document Type: Article

References (25)

1. Planche T., Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards?. J Clin Pathol 2010, 1:1-5.
2. Goldenberg SD, French GL. Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect, in press.
3. Planche T., Aghaizu A., Holliman R., Riley P., Poloniecki J., Breathnach A., et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8:777-784.
4. Crobach M.J., Dekkers O.M., Wilcox M.H., Kuijper E.J. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009, 15:1053-1066.
5. Eastwood K., Else P., Charlett A., Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdb, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217.
6. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
7. Kvach E.J., Ferguson D., Riska P.F., Landry M.L. Comparison of BD geneohm cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010, 48:109-114.
8. Novak-Weekley S.M., Marlowe E.M., Miller J.M., Cumpio J., Nomura J.H., Vance P.H., et al. Clostridium difficile testing in the clinical laboratory using multiple testing algorithms. J Clin Microbiol 2010, 48:889-893.
9. Wilcox M.H., Planche T., Fang F.C. Point-Counterpoint: what is the current role of algorithmic approaches for the diagnosis of C. difficile infection?. J Clin Microbiol 2010, 48:4347-4353.
10. Arnold A., Pope C., Bray S., Riley P., Breathnach A., Krishna S., et al. Prospective assessment of two-stage testing for Clostridium difficile. J Hosp Infect 2010, 76:18-22.
11. Goldenberg S.D., Cliff P.R., Smith S., Milner M., French G.L. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile. J Hosp Infect 2010, 74:48-54.
12. Goldenberg S.D., Dieringer T., French G.L. Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2010, 67:304-307.
13. Shetty N., Wren M.W., Coen P.G. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J Hosp Infect 2011, 1:1-6.
14. Sharp S.E., Ruden L.O., Pohl J.C., Hatcher P.A., Jayne L.M., Ivie W.M. Evaluation of the C. diff quik chek complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 2010, 48:2082-2086.
15. Swindells J., Brenwald N., Reading N., Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010, 48:606-608.
16. Planche T.D., Wilcox M.H. Two-step testing for C. difficile: no answers yet. J Hosp Infect 2010, 75:325-326. author reply 326-7.
17. Goldenberg S.D., Cliff P.R., French G.L., Sharp S.E. Glutamate dehydrogenase for laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol 2010, 48:3050-3051.
18. Stubbs S.L., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999, 37:461-463.
19. Otter J.A., Havill N.L., Adams N.M., Cooper T., Tauman A., Boyce J.M. Environmental sampling for Clostridium difficile: swabs or sponges?. Am J Infect Control 2009, 37:517-518.
20. Babady N.E., Stiles J., Ruggiero P., Khosa P., Huang D., Shuptar S., et al. Evaluation of the Cepheid Xpert Clostridium difficile epi assay for diagnosis C. difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010, 48:4519-4524.
21. Dumford D.M., Nerandzic M.M., Eckstein B.C., Donskey C.J. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with north american pulsed-field gel electrophoresis type 1 strains. Am J Infect Control 2009, 37:15-19.
22. Weber D.J., Rutala W.A., Miller M.B., Huslage K., Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and acinetobacter species. Am J Infect Control 2010, 38:S25-S33.
23. Duerden B.I. Contribution of a government target to controlling Clostridium difficile in the nhs in England. Anaerobe 2010, 10.1016/j.anaerobe.2010.12.004.
24. Shekelle Lim, Mattke Damberg Does public release of performance results improve quality of care? A sytematic review 2008, RAND Corporation/The Health Foundation.
25. Walker A.S., Spiegelhalter D., Crook D.W., Wyllie D., Morris J., Peto T.E. Fairness of financial penalties to improve control of Clostridium difficile. BMJ 2008, 337:a2097.